Download full-text PDF |
Source |
---|
Neurobiol Pain
July 2021
Division of Infectious Diseases, Department of Internal Medicine, Mayo Clinic, Jacksonville, FL, USA.
The cholecystokinin B receptor and its neuropeptide ligand are upregulated in chronic neuropathic pain models. Single-chain Fragment variable antibodies were generated as preferred non-opioid targeting therapy blocking the cholecystokinin B receptor to inhibit chronic neuropathic pain models and . Engineered antibodies of this type feature binding activity similar to monoclonal antibodies but with stronger affinity and increased tissue penetrability due to their smaller size.
View Article and Find Full Text PDFTrials
May 2018
Emergency Department, Nantes University Hospital, 44000, Nantes, France.
Background: Acute pain is a common condition among prehospital patients and prompt management is pivotal. Opioids are the most frequently analgesics used in the prehospital setting. However, opioids are highly addictive, and some patients may develop opioid dependence, even when they are exposed to brief opioid treatments.
View Article and Find Full Text PDFBull Exp Biol Med
December 2016
Far Eastern State Medical University, Ministry of Health of Russian Federation, Khabarovsk, Russia.
We studied the possibility of correction of the negative effects of antenatal hypoxia on the liver tissue homeostasis in 7-day-old albino rats by administration of opioid peptides in a dose of 100 μg/kg on postnatal days 2-6. Administration of mixed μ/δ-opioid receptor agonist Dalargin neutralized deviations of gravimetric indicators, parameters of proliferative activity, and activity of the nucleolar apparatus of hepatocytes. Administration of the non-opiate Leu-enkephalin analogue did not normalize gravimetric parameters and nucleolar apparatus parameters, however, it significantly increased the pool of proliferating hepatocytes.
View Article and Find Full Text PDFNeurogastroenterol Motil
January 2012
Department of Biological Sciences, University of Idaho, Moscow, ID 83844-3051, USA.
Background: Garcinia buchananii bark extract is an anti-motility diarrhea remedy. We investigated whether G. buchananii bark extract has components that reduce gastrointestinal peristaltic activity via 5-HT(3) and 5-HT(4) receptors.
View Article and Find Full Text PDFEnter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!